Imaging of integrin α(v)β(3) expression in patients with malignant glioma by [(18)F] Galacto-RGD positron emission tomography

Inhibitors targeting the integrin α(v)β(3) are promising new agents currently tested in clinical trials for supplemental therapy of glioblastoma multiforme (GBM). The aim of our study was to evaluate (18)F-labeled glycosylated Arg-Gly-Asp peptide ([(18)F]Galacto-RGD) PET for noninvasive imaging of α...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schnell, Oliver, Krebs, Bjarne, Carlsen, Janette, Miederer, Isabelle, Goetz, Claudia, Goldbrunner, Roland H., Wester, Hans-Jürgen, Haubner, Roland, Pöpperl, Gabriele, Holtmannspötter, Markus, Kretzschmar, Hans A., Kessler, Horst, Tonn, Jörg-Christian, Schwaiger, Markus, Beer, Ambros J.
Formato: Artigo
Idioma:Inglês
Publicado em: Duke University Press 2009
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2802406/
https://ncbi.nlm.nih.gov/pubmed/19401596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2009-024
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados